ATE394937T1 - Mit morinda citrifolia (noni) angereichtertes futtermittelprodukt - Google Patents

Mit morinda citrifolia (noni) angereichtertes futtermittelprodukt

Info

Publication number
ATE394937T1
ATE394937T1 AT02252679T AT02252679T ATE394937T1 AT E394937 T1 ATE394937 T1 AT E394937T1 AT 02252679 T AT02252679 T AT 02252679T AT 02252679 T AT02252679 T AT 02252679T AT E394937 T1 ATE394937 T1 AT E394937T1
Authority
AT
Austria
Prior art keywords
noni
morinda citrifolia
animal food
feed product
product enriched
Prior art date
Application number
AT02252679T
Other languages
English (en)
Inventor
John Wadsworth
Stephen P Story
Claude Jarkae Jensen
Original Assignee
Tahitian Noni Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tahitian Noni Int Inc filed Critical Tahitian Noni Int Inc
Application granted granted Critical
Publication of ATE394937T1 publication Critical patent/ATE394937T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
AT02252679T 2001-04-17 2002-04-16 Mit morinda citrifolia (noni) angereichtertes futtermittelprodukt ATE394937T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/836,881 US6737089B2 (en) 1999-08-27 2001-04-17 Morinda citrifolia (Noni) enhanced animal food product

Publications (1)

Publication Number Publication Date
ATE394937T1 true ATE394937T1 (de) 2008-05-15

Family

ID=25272957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02252679T ATE394937T1 (de) 2001-04-17 2002-04-16 Mit morinda citrifolia (noni) angereichtertes futtermittelprodukt

Country Status (5)

Country Link
US (1) US6737089B2 (de)
EP (1) EP1250849B1 (de)
JP (2) JP2003061588A (de)
AT (1) ATE394937T1 (de)
DE (1) DE60226537D1 (de)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
US8652546B2 (en) * 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US20120237626A9 (en) * 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
US7244463B2 (en) * 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
WO2002083159A1 (en) * 2001-04-17 2002-10-24 Morinda, Inc. Palliative effects of morinda citrifolia oil and juice
WO2002098433A1 (en) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Drugs for intestinal diseases
GB0113348D0 (en) * 2001-06-01 2001-07-25 Mars Uk Ltd Skin diet
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
US7074451B2 (en) * 2001-09-19 2006-07-11 Conagra Grocery Products Company System and method for producing concentrated food products with fractionation concentration
US20030134002A1 (en) * 2001-11-02 2003-07-17 Jensen Claude Jarakae Method for treating visual impairment through the prophylactic administration of a Morinda citrifolia-based naturaceutical
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US20040037942A1 (en) * 2002-08-20 2004-02-26 Shah Naina Kiran Composition
EA009076B1 (ru) * 2002-08-30 2007-10-26 Кампина Б.В. Пенообразующий ингредиент и продукты, содержащие такой ингредиент
US8034372B2 (en) * 2003-03-05 2011-10-11 Nestec, Ltd. Dietary supplement for athletic pets
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
WO2004096252A1 (en) * 2003-04-25 2004-11-11 Primavera Biosciences, Inc. Compositions and methods for weight loss
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
WO2005000331A2 (en) * 2003-06-04 2005-01-06 Mucosal Therapeutics, Inc. Compositions for the treatment and prevention of degenerative joint disorders
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
US20050037101A1 (en) * 2003-08-12 2005-02-17 Mian-Ying Wang Preventative effects of morinda citrifolia on mammary breast cancer
US20050084551A1 (en) * 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US7754677B2 (en) * 2003-12-05 2010-07-13 Hill's Pet Nutrition, Inc. Composition and method for reducing diarrhea in a mammal
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050158412A1 (en) * 2004-01-05 2005-07-21 Chen Su Type II diabetes
US8377904B2 (en) * 2004-02-09 2013-02-19 Hill's Pet Nutrition, Inc. Composition and method for use in cartilage affecting conditions
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
US20050202108A1 (en) * 2004-03-10 2005-09-15 Palu Afa K. Methods and compositions for inhibiting angiotensin converting and chymase enzymes
US20050260291A1 (en) * 2004-03-10 2005-11-24 Palu Afa K Methods and compositions for reactivating acetylcholinesterase
US8685438B2 (en) * 2004-03-17 2014-04-01 The Iams Company Compositions, kits, and methods utilizing an added boron source
US20050238654A1 (en) * 2004-04-26 2005-10-27 Yoshinori Takeda Compositions and methods for weight loss
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US7112343B1 (en) * 2004-05-24 2006-09-26 Robbie Shoemake Immune system reconstructor composition
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
DK1758469T4 (da) * 2004-06-22 2013-11-04 Nutricia Nv Forbedring af barriereintegriteten hos HIV-patienter ved anvendelse af fedtsyrer
EP1721611A1 (de) * 2005-04-21 2006-11-15 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
EP1723951A1 (de) * 2005-04-21 2006-11-22 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
WO2006047416A2 (en) * 2004-10-25 2006-05-04 Wadsworth John W Garcinia mangostana l. enhanced animal food product
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
NZ562462A (en) * 2005-04-21 2011-04-29 Nutricia Nv Nutritional supplement for HIV patients comprising acid and neutral oligosaccharides.
US7536364B2 (en) * 2005-04-28 2009-05-19 General Electric Company Method and system for performing model-based multi-objective asset optimization and decision-making
US20060247798A1 (en) * 2005-04-28 2006-11-02 Subbu Rajesh V Method and system for performing multi-objective predictive modeling, monitoring, and update for an asset
WO2006121803A1 (en) 2005-05-05 2006-11-16 Sensient Flavors Inc. Production of beta-glucans and mannans
US7700142B2 (en) * 2005-05-16 2010-04-20 Diane Wright Hoffpauer Fortified cereal bran to promote digestive health
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
EP1885383B1 (de) 2005-05-31 2016-09-21 IAMS Europe B.V. Katzen probiotisches bifidobacterium
DE102005031364A1 (de) * 2005-06-30 2007-01-11 Ernst-Moritz-Arndt-Universität Greifswald Nahrungsergänzungsmittel mit verbesserten antioxidativen Eigenschaften
EP2324838A1 (de) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Zusammensetzungen mit Dimethyl-Sulfoxid
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
CA2622204C (en) 2005-09-12 2016-10-11 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
US20070071809A1 (en) * 2005-09-26 2007-03-29 Vad Vijay B Ginger containing compositions to control pain
US20070184137A1 (en) * 2005-11-29 2007-08-09 Palu Afa K Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes
US20070166417A1 (en) * 2005-11-29 2007-07-19 Palu Afa K Formulation and Methods for Use of Morinda Citrifolia Seed Oil
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
JP2007169247A (ja) * 2005-12-26 2007-07-05 Seikatsu Bunkasha:Kk ショウガ含有経口組成物
KR20080088641A (ko) * 2006-01-20 2008-10-02 타히티안 노니 인터내셔날, 인크. 동물 투여용 모린다 시트리폴리아 강화 제품
US20070298142A1 (en) * 2006-01-20 2007-12-27 Godbee Richard G Morinda Citrifolia Enhanced Products For Administration To Animals
BRPI0621518B1 (pt) * 2006-03-21 2022-05-10 Taminco Método para o tratamento não terapêutico das aves domésticas, ração para aves domésticas, e, uso de um composto de glicina e/ou de um sal do mesmo
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
CA2654146A1 (en) * 2006-06-08 2008-01-17 The Iams Company Composition for improving eye health
FR2903860B1 (fr) * 2006-07-21 2010-12-31 Royal Canin Sa Aliment sec pour reduire l'appetit des chiens
WO2008093302A2 (en) * 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and oxidative stress in mammals
PL2124966T3 (pl) * 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
US20080206368A1 (en) * 2007-02-26 2008-08-28 Mian-Ying Wang Administration of Morinda Citrifolia L. Based Formulations to Increase Birth Rates
US9420807B2 (en) * 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
WO2009033502A1 (en) * 2007-09-12 2009-03-19 Taminco Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
JP5436895B2 (ja) * 2009-03-13 2014-03-05 サントリーホールディングス株式会社 水抽出コンドロイチンおよびミルク香料を含む経口製剤
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP4786000B2 (ja) * 2009-10-16 2011-10-05 株式会社カネカ 還元型補酵素ｑ１０の製造方法、安定化方法及びそれを含有する組成物
EP2493314B1 (de) 2009-10-30 2020-04-08 Abela Pharmaceuticals, Inc. Dimethylsulfoxid (dmso)- und methylsulfonylmethan (msm)-formulierungen zur behandlung von osteoarthritis
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
WO2012050979A1 (en) * 2010-09-29 2012-04-19 Jiantao Gao Novel feed additive
ES2386474B1 (es) 2011-01-21 2013-07-09 Norel, Sa Aditivos para alimentación animal.
KR20140063616A (ko) 2011-07-20 2014-05-27 브라이엄 영 유니버시티 소수성 세라게닌 화합물 및 이를 포함하는 기구
CN102524539B (zh) * 2012-01-18 2013-04-03 丁国成 一种动物保健剂组合物及其制备工艺
WO2013165574A2 (en) 2012-05-02 2013-11-07 Brigham Young University Ceragenin particulate materials and methods for making same
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
CN103404701B (zh) * 2013-08-26 2015-08-05 成都乾坤动物药业有限公司 一种改善禽畜肌肉口感的兽用组合物及其制备方法和用途
CN103704492A (zh) * 2013-09-06 2014-04-09 广德优维坊宠物食品有限公司 一种宠物强效亮毛增色组合
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
HU230683B1 (hu) * 2014-07-03 2017-08-28 Emil Szanto Korpát tartalmazó étrend kiegészítõ és roboráló készítmény
CN104171436B (zh) * 2014-09-11 2016-04-06 东北农业大学 一种肉用鹌鹑抗冷应激且同时改善肉质的饲料添加剂及饲料
KR101675456B1 (ko) * 2014-11-21 2016-11-15 (주) 에이티바이오 면역력 향상용 사료 및 면역력 향상용 사료의 제조방법
KR101652075B1 (ko) * 2015-04-28 2016-08-29 강석상 적색 셰일을 이용한 가축사료 조성물
CN104872395B (zh) * 2015-06-05 2018-06-19 西双版纳华坤生物科技有限责任公司 一种富含ω-3脂肪酸和共轭亚油酸的牛奶及其生产方法
ES2952744T3 (es) * 2016-12-15 2023-11-03 Nestle Sa Composiciones y procedimientos que modulan los glóbulos blancos o los neutrófilos en un animal de compañía
CN106852936A (zh) * 2016-12-21 2017-06-16 泰州市贝诺生物科技有限公司 宠物壮骨关节膏及其制备方法
US10287366B2 (en) 2017-02-15 2019-05-14 Cp Kelco Aps Methods of producing activated pectin-containing biomass compositions
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
KR102609440B1 (ko) * 2021-05-28 2023-12-05 로얄캐니펠 주식회사 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5431927A (en) 1992-06-16 1995-07-11 Colgate-Palmolive Company Pet food product having oral care properties
US5288491A (en) * 1992-09-24 1994-02-22 Herbert Moniz Noni (Morinda Citrifolia) as a pharmaceutical product
US5616569A (en) 1994-03-28 1997-04-01 The Iams Company Pet food product containing fermentable fibers and process for treating gastrointestinal disorders
US5962043A (en) 1996-02-29 1999-10-05 Seal Rock Technologies Incorporated Weight reduction method for dogs and other pets
US6133323A (en) 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
US5851573A (en) 1997-04-29 1998-12-22 The Iams Company Pet food composition for large breed puppies and method for promoting proper skeletal growth
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
US6405948B1 (en) * 1997-07-18 2002-06-18 Pulsewave Llc Liberating intracellular matter from biological material
US6039952A (en) 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
US5976549A (en) * 1998-07-17 1999-11-02 Lewandowski; Joan Method to reduce bad breath in a pet by administering raw garlic
FR2783137A1 (fr) * 1998-09-10 2000-03-17 Royal Tahiti Noni Composition a base d'extraits de morinda citrifolia
US6156355A (en) 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
US6299925B1 (en) * 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
US6214351B1 (en) * 1999-08-27 2001-04-10 Morinda, Inc. Morinda citrifolia oil
US6254913B1 (en) * 1999-08-27 2001-07-03 Morinda, Inc. Morinda citrifolia dietary fiber and method
US6436449B2 (en) * 2000-03-02 2002-08-20 Bo Gidlund Use of a composition
SE516468C2 (sv) * 2000-03-02 2002-01-15 Bo Gidlund Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus.

Also Published As

Publication number Publication date
EP1250849A1 (de) 2002-10-23
JP2003061588A (ja) 2003-03-04
US6737089B2 (en) 2004-05-18
US20020182276A1 (en) 2002-12-05
EP1250849B1 (de) 2008-05-14
DE60226537D1 (de) 2008-06-26
JP2006280382A (ja) 2006-10-19

Similar Documents

Publication Publication Date Title
ATE394937T1 (de) Mit morinda citrifolia (noni) angereichtertes futtermittelprodukt
SE0202241D0 (sv) Novel Compounds
DK0798968T3 (da) Middel til at forbedre produktionen og avlen af produktionsdyr inden for fjerkræsindustrien
ID28024A (id) Metode bagi produksi 1,3-propanadiol oleh organisme-organisme rekombinan yang mengandung ge-gen untuk pengakutan vitamin b12
TW200407305A (en) Novel compounds
BRPI0414598A (pt) indóis substituìdos
TW200510301A (en) Novel compounds
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
ATE408601T1 (de) Fredericamycin-derivate
ATE433671T1 (de) Verfahren und zusammensetzung zur vergroesserung der milchproduktion
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
ITMI911683A1 (it) Procedimento per la produzione di alimenti complessi a lunga conservazione, pronti da consumare.
WO1998041513A3 (de) Substituierte aminosalicylsäureamide mit fungizider wirkung und zwischenprodukte zu ihrer herstellung
EE03589B1 (et) Kanamuna, kanasööt ja kanamunade saamismeetod
ATE406884T1 (de) Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits
ATE372776T1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
PA8448601A1 (es) Producto alimenticio congelado
WO2003105751A3 (en) Novel curcumin derivatives
ITMI20022704A1 (it) Procedimento per la produzione di mesitilene e durene.
ES1051709Y (es) Fosa para la descomposicion de cadaveres animales.
EP1565448A4 (de) VERFAHREN ZUR HERSTELLUNG VON10H-DIBENZOçB, F] ç1,4]THIAZEPIN-11-ON
NO20031261L (no) Dyrefôrsupplement som inneholder D-pantotensyre og/eller dens salter, forbedret fremgangsmåte for fremstilling derav samt anvendelse derav
WO2006047416A3 (en) Garcinia mangostana l. enhanced animal food product
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
EA200600115A1 (ru) Производные 2-аминобензойной кислоты

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250849

Country of ref document: EP